Clover Health CEO Sells 220,426 Shares Amid Strong Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: Fool
- Transaction Overview: On May 28, 2026, Conrad Wai sold 220,426 shares of Clover Health stock in an indirect open-market transaction, generating approximately $879,000, which reflects his confidence in the company's future prospects.
- Ownership Structure Analysis: Post-transaction, Wai retains 2,559,970 shares of Class A Common Stock, with indirect holdings of 1,390,056 shares and direct holdings of 1,169,914 shares, indicating his continued commitment to maintaining control over the company.
- Market Context and Reaction: The shares were sold at $3.99 each, between the day's opening price of $3.64 and closing price of $4.18, reflecting a positive market response to the company's strong performance.
- Company Performance Highlights: Clover Health reported a 62% revenue increase in Q1, reaching $749.2 million, primarily driven by a 51% growth in Medicare Advantage membership, showcasing its robust position in the healthcare insurance market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CLOV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CLOV
Wall Street analysts forecast CLOV stock price to fall
2 Analyst Rating
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 3.990
Low
3.00
Averages
3.35
High
3.70
Current: 3.990
Low
3.00
Averages
3.35
High
3.70
About CLOV
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Conrad Wai Sells 220,426 Shares of Clover Health Stock
- Share Sale Details: Conrad Wai sold 220,426 shares of Clover Health stock at $3.99 per share, totaling approximately $879,000, demonstrating his strategic decision-making at a market peak.
- Ownership Structure: Post-sale, Wai retains 1,169,914 shares directly and 1,390,056 shares indirectly, indicating his confidence in the company's future and long-term investment intentions.
- Trading Plan Context: The transaction was executed under a Rule 10b5-1 trading plan established in March 2025, aimed at avoiding insider trading accusations, showcasing Wai's transparency and compliance.
- Market Performance Impact: On the day of the sale, Clover's stock hit a 52-week high of $4.23, reflecting the company's strong first-quarter performance with a 62% year-over-year revenue increase, highlighting its robust growth potential in the Medicare market.
See More
Clover Health CEO Sells 220,426 Shares Amid Strong Growth
- Transaction Overview: On May 28, 2026, Conrad Wai sold 220,426 shares of Clover Health stock in an indirect open-market transaction, generating approximately $879,000, which reflects his confidence in the company's future prospects.
- Ownership Structure Analysis: Post-transaction, Wai retains 2,559,970 shares of Class A Common Stock, with indirect holdings of 1,390,056 shares and direct holdings of 1,169,914 shares, indicating his continued commitment to maintaining control over the company.
- Market Context and Reaction: The shares were sold at $3.99 each, between the day's opening price of $3.64 and closing price of $4.18, reflecting a positive market response to the company's strong performance.
- Company Performance Highlights: Clover Health reported a 62% revenue increase in Q1, reaching $749.2 million, primarily driven by a 51% growth in Medicare Advantage membership, showcasing its robust position in the healthcare insurance market.
See More
Clover Health Reports Poor Quarterly Performance
- Quarterly Performance Analysis: Clover Health Investments reported a disappointing quarter, with revenues being acceptable but earnings falling short of expectations, indicating uncertainty in the company's market position and advising investors to approach stock price fluctuations with caution.
- Market Reaction Observation: Despite a rise in Clover Health's stock price, analysts caution that this increase may be speculative, as the fundamentals have not improved, reflecting concerns about the company's future development in the market.
- Industry Comparison: Compared to other firms, Clover Health's profitability is weaker, particularly in the healthcare investment sector, which may lead to a decline in investor confidence regarding its long-term growth potential.
- Investment Recommendations: Analysts maintain a cautious stance on investing in Clover Health, suggesting that in the absence of clear profit guidance, investors should consider other more stable investment options.
See More
Investor Sentiments on Joby Aviation
- Investment Outlook: Joby Aviation is viewed as a promising investment, although market sentiment remains cautious; analysts suggest that the upcoming investment wave in the drone sector could benefit Joby significantly.
- Competitive Landscape: In the drone industry, analysts indicate that other companies may present more attractive investment opportunities, especially with the presidential election potentially driving further growth in the sector.
- Industry Dynamics: Despite Joby Aviation's strong stock performance, analysts express concerns about its profitability, noting that the company is still operating at a loss, which necessitates careful evaluation of its long-term value by investors.
- Investor Confidence Boost: As interest in drone technology rises, Joby Aviation's market visibility improves, leading analysts to adopt an optimistic stance on its future investment prospects, which may attract more investor attention.
See More
Bentley Systems Faces Disruption from AI Technologies
- Software Disruption Risk: Bentley Systems acknowledges that its software market is being disrupted by artificial intelligence, which could impact its future market share and revenue growth, particularly in the construction and engineering sectors.
- Housing Market Demand: Pool Corporation highlights that insufficient housing turnover is a major barrier to its business growth, indicating that a sluggish real estate market may negatively affect its sales.
- Dividend Appeal: Realty Income expresses confidence in its dividend strategy, believing that its dividends will attract more investors and potentially drive stock price increases, reflecting market demand for stable income.
- Investor Confidence: Jim Cramer's investment advice indicates a strong market confidence in long-term investments, especially in uncertain economic conditions, emphasizing the importance of sound investment strategies.
See More
Clover Health Reports Strong Q1 2026 Earnings with 51% Membership Growth
- Significant Membership Growth: Clover Health achieved a 51% year-over-year increase in membership in Q1 2026, reaching approximately 156,000 members, which drove total revenues to $749 million, up 62%, showcasing its strong growth potential in the Medicare market.
- Improved Profitability: The company reported a GAAP net income of $27 million in the first quarter, reflecting ongoing improvements in profitability while maintaining market-leading growth, indicating the sustainability of its business model.
- Operational Efficiency Optimization: The insurance loss ratio for the quarter was 86.5%, while adjusted SG&A expenses were $119 million, or 16% of revenue, improving by approximately 200 basis points year-over-year, demonstrating positive progress in cost control and operational efficiency.
- Optimistic Future Outlook: Management expects to achieve full-year GAAP net income profitability in 2026 and to exceed expectations across all metrics, although they emphasize a cautious approach until more complete data is available to ensure robust business development.
See More
Conrad Wai Sells 220,426 Shares of Clover Health Stock
- Share Sale Details: Conrad Wai sold 220,426 shares of Clover Health stock at $3.99 per share, totaling approximately $879,000, demonstrating his strategic decision-making at a market peak.
- Ownership Structure: Post-sale, Wai retains 1,169,914 shares directly and 1,390,056 shares indirectly, indicating his confidence in the company's future and long-term investment intentions.
- Trading Plan Context: The transaction was executed under a Rule 10b5-1 trading plan established in March 2025, aimed at avoiding insider trading accusations, showcasing Wai's transparency and compliance.
- Market Performance Impact: On the day of the sale, Clover's stock hit a 52-week high of $4.23, reflecting the company's strong first-quarter performance with a 62% year-over-year revenue increase, highlighting its robust growth potential in the Medicare market.
See More
Clover Health CEO Sells 220,426 Shares Amid Strong Growth
- Transaction Overview: On May 28, 2026, Conrad Wai sold 220,426 shares of Clover Health stock in an indirect open-market transaction, generating approximately $879,000, which reflects his confidence in the company's future prospects.
- Ownership Structure Analysis: Post-transaction, Wai retains 2,559,970 shares of Class A Common Stock, with indirect holdings of 1,390,056 shares and direct holdings of 1,169,914 shares, indicating his continued commitment to maintaining control over the company.
- Market Context and Reaction: The shares were sold at $3.99 each, between the day's opening price of $3.64 and closing price of $4.18, reflecting a positive market response to the company's strong performance.
- Company Performance Highlights: Clover Health reported a 62% revenue increase in Q1, reaching $749.2 million, primarily driven by a 51% growth in Medicare Advantage membership, showcasing its robust position in the healthcare insurance market.
See More
Clover Health Reports Poor Quarterly Performance
- Quarterly Performance Analysis: Clover Health Investments reported a disappointing quarter, with revenues being acceptable but earnings falling short of expectations, indicating uncertainty in the company's market position and advising investors to approach stock price fluctuations with caution.
- Market Reaction Observation: Despite a rise in Clover Health's stock price, analysts caution that this increase may be speculative, as the fundamentals have not improved, reflecting concerns about the company's future development in the market.
- Industry Comparison: Compared to other firms, Clover Health's profitability is weaker, particularly in the healthcare investment sector, which may lead to a decline in investor confidence regarding its long-term growth potential.
- Investment Recommendations: Analysts maintain a cautious stance on investing in Clover Health, suggesting that in the absence of clear profit guidance, investors should consider other more stable investment options.
See More
Investor Sentiments on Joby Aviation
- Investment Outlook: Joby Aviation is viewed as a promising investment, although market sentiment remains cautious; analysts suggest that the upcoming investment wave in the drone sector could benefit Joby significantly.
- Competitive Landscape: In the drone industry, analysts indicate that other companies may present more attractive investment opportunities, especially with the presidential election potentially driving further growth in the sector.
- Industry Dynamics: Despite Joby Aviation's strong stock performance, analysts express concerns about its profitability, noting that the company is still operating at a loss, which necessitates careful evaluation of its long-term value by investors.
- Investor Confidence Boost: As interest in drone technology rises, Joby Aviation's market visibility improves, leading analysts to adopt an optimistic stance on its future investment prospects, which may attract more investor attention.
See More
Bentley Systems Faces Disruption from AI Technologies
- Software Disruption Risk: Bentley Systems acknowledges that its software market is being disrupted by artificial intelligence, which could impact its future market share and revenue growth, particularly in the construction and engineering sectors.
- Housing Market Demand: Pool Corporation highlights that insufficient housing turnover is a major barrier to its business growth, indicating that a sluggish real estate market may negatively affect its sales.
- Dividend Appeal: Realty Income expresses confidence in its dividend strategy, believing that its dividends will attract more investors and potentially drive stock price increases, reflecting market demand for stable income.
- Investor Confidence: Jim Cramer's investment advice indicates a strong market confidence in long-term investments, especially in uncertain economic conditions, emphasizing the importance of sound investment strategies.
See More
Clover Health Reports Strong Q1 2026 Earnings with 51% Membership Growth
- Significant Membership Growth: Clover Health achieved a 51% year-over-year increase in membership in Q1 2026, reaching approximately 156,000 members, which drove total revenues to $749 million, up 62%, showcasing its strong growth potential in the Medicare market.
- Improved Profitability: The company reported a GAAP net income of $27 million in the first quarter, reflecting ongoing improvements in profitability while maintaining market-leading growth, indicating the sustainability of its business model.
- Operational Efficiency Optimization: The insurance loss ratio for the quarter was 86.5%, while adjusted SG&A expenses were $119 million, or 16% of revenue, improving by approximately 200 basis points year-over-year, demonstrating positive progress in cost control and operational efficiency.
- Optimistic Future Outlook: Management expects to achieve full-year GAAP net income profitability in 2026 and to exceed expectations across all metrics, although they emphasize a cautious approach until more complete data is available to ensure robust business development.
See More
